News

Member Portal

FDA Approves Bkemv, an Interchangeable Biosimilar to Soliris

May 28, 2024

Scientists May Have Located Your Brain’s ‘Neural Compass’

May 7, 2024

Dr. Reddy’s Issues Recall of Sapropterin Dihydrochloride Powder

May 7, 2024

AI Might Spot Rare Diseases in Patients Years Earlier

May 3, 2024

Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify® Tablets Dueto Drug Product Cross-Contamination on Manufacturing Equipment

April 30, 2024

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

By submitting this form, you are consenting to receive marketing emails from: Benecard Services, LLC. (Lawrenceville, NJ 08648), https://www.benecard.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.

News

FDA Approves Bkemv, an Interchangeable Biosimilar to Soliris

YESAFILI AND OPUVIZ

IMDELLTRA™

GENERIC DRUG APPROVALS

Scientists May Have Located Your Brain’s ‘Neural Compass’

Dr. Reddy’s Issues Recall of Sapropterin Dihydrochloride Powder

MYHIBBIN™

AI Might Spot Rare Diseases in Patients Years Earlier

Otsuka Initiates Voluntary Nationwide Recall of Certain Lots of Abilify® Tablets Dueto Drug Product Cross-Contamination on Manufacturing Equipment

Benefit Advisors & Employees - Want to know more?

Benecard

Newsletter